CAMBRIDGE TRUST CO - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAMBRIDGE TRUST CO ownership history of REGENXBIO INC
ValueSharesWeighting
Q3 2023$6,090
-17.7%
3700.0%0.00%
Q2 2023$7,396
+5.7%
3700.0%0.00%
Q1 2023$6,997
+87362.5%
3700.0%0.00%
Q4 2022$8
-99.9%
3700.0%0.00%
Q3 2022$10,000
+11.1%
3700.0%0.00%
Q2 2022$9,000
-25.0%
3700.0%0.00%
Q1 2022$12,0000.0%3700.0%0.00%
Q4 2021$12,0003700.00%
Other shareholders
REGENXBIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 831,014$15,714,4756.51%
MPM BioImpact LLC 617,671$11,680,1593.03%
Sonic GP LLC 193,079$3,651,1242.79%
ArchPoint Investors 224,278$4,241,0971.84%
Redmile Group, LLC 1,640,725$31,026,1101.35%
MIRABELLA FINANCIAL SERVICES LLP 25,983$5,461,3440.83%
WS MANAGEMENT LLLP 396,997$7,507,2130.79%
Redwood Wealth Management Group, LLC 15,190$287,2430.33%
SummerHaven Investment Management, LLC 27,503$520,0820.30%
Lombard Odier Asset Management (Switzerland) SA 130,369$2,465,2780.22%
View complete list of REGENXBIO INC shareholders